Wednesday, July 8, 2026

pharma · Solid Tumors · Primary Dysmenorrhea

Topiloric/Uriadec

Topiloric/Uriadec is a pharma organization headquartered in SOUTH SAN FRANCISCO, CA, JP. Primary therapeutic focus areas include Solid Tumors, Primary Dysmenorrhea, Prostate cancer, chronic liver disease, Prostatic Neopl

SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
Status
Public
HQ
SOUTH SAN FRANCISCO, CA, JP
Employees
2
Programs
12
Drugs
7
Patents
52
Clinical program

ORIC-101

Phase 1 · small molecule · Healthy Volunteers

ORIC-101 for Healthy Volunteers is a Phase 1 program (small_molecule) at Topiloric/Uriadec with 2 ClinicalTrials.gov record(s).

← All Topiloric/Uriadec projects Phase 1 small molecule completed

Internal code ORIC-GR-17001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Topiloric/Uriadec
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Volunteers
Status
completed
Trials
2

Clinical trials